476060.KQ KOE
Onconic Therapeutics
1W: +3.8%
1M: -12.7%
3M: +14.8%
YTD: -8.8%
1Y: -37.8%
₩15,710.00 ($11.70)
-210.00 (-1.32%)
Weekly Expected Move ±6.2%
₩13769
₩14739
₩15710
₩16681
₩17651
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩173.9B ($129.5M)
52W Range8790-28900
Volume177,051
Avg Volume551,121
Beta0.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJohn Kim
Employees38
SectorHealthcare
IndustryBiotechnology
IPO Date2024-12-19
Websiteonconic.co.kr
11th Floor, Star Building, 12 Teheran-ro 26-gil, Gangnam-gu
Seoul, SL 06236
KR
Seoul, SL 06236
KR
82 2 345-40780
About Onconic Therapeutics
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found